TenNor Announces Positive Topline Results from Rifasutenizol Phase III Trial for H. pylori Infection
SUZHOU,China,Nov 18,2024-- TenNor Therapeutics,a clinical-stage company dedicated to developing novel therapies to address unmet needs in infectious diseases,announced today the successful completion